Statistical flags indicate unusual patterns — not proof of fraud or wrongdoing. Read our methodology

USA Biosciences LLC

Clinical Medical Laboratory·Torrance, CA·NPI: 1548771736SharePrint Report

Red Flags Explained

Each flag represents a statistical test that identified unusual billing patterns. Here's what each flag on this provider means in plain English:

Billing Swing

Billing Swing means this provider's total billing changed dramatically from one year to the next — increasing or decreasing by more than 200% with over $1M in absolute change. This could indicate a change in practice scope, a billing scheme ramping up, or legitimate growth.

Explosive Growth

Explosive Growth means this provider's billing increased by more than 500% year-over-year. While rapid expansion can be legitimate, this pattern has been observed in fraud schemes that ramp up billing quickly before detection.

These flags are statistical indicators only. Many flagged providers have legitimate explanations for their billing patterns. Learn more about our methodology.

Compared to Clinical Medical Laboratory Peers

Total spending distribution among 88 providers in this specialty

P25MedianP75P90

This provider's total spending of $18.5M is at the 25th percentile among 88 Clinical Medical Laboratory providers.

Total Paid

$18.5M

$18,541,620

Total Claims

0

Beneficiaries

0

Avg Cost/Claim

$0

🔍 Analysis

Provider Overview

USA Biosciences LLC is a Clinical Medical Laboratory provider based in Torrance, CA. From the 2018–2024 period, this provider received $0 in Medicaid payments across 0 claims.

Procedure Breakdown

Cost per claim compared to national benchmarks

This provider bills for 10 distinct procedure codes. The top code (87502 (Influenza virus detection, reverse transcription, amplified probe)) accounts for 37% of total spending.

Influenza virus detection, reverse transcription, amplified probe

$6.8M

112K claims · 36.7%

$5.5M

112K claims · 29.7%

COVID-19 SARS-CoV-2 amplified probe detection

$4.6M

110K claims · 24.8%

Infectious disease detection (COVID-19)

$1.2M

28K claims · 6.3%

Specimen collection for COVID-19 testing

$267K

26K claims · 1.4%

Infectious agent detection, nucleic acid, not otherwise specified

$105K

3K claims · 0.6%

Infectious disease detection, COVID-19, antigen

$34K

16K claims · 0.2%

Respiratory virus detection, 3-5 targets, nucleic acid

$22K

2K claims · 0.1%

$7K

866 claims · 0.0%

$7K

2K claims · 0.0%